Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Br J Anaesth ; 77(4): 492-5, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8942334

ABSTRACT

The reported effects of edrophonium on a subsequent dose of suxamethonium are variable and the effects of pyridostigmine have not been evaluated extensively. We have studied this interaction in patients anaesthetized with propofol and sufentanil. After recovery from an initial bolus (1 mg kg-1) of suxamethonium, vecuronium was infused to produce 75% block. After 30 min, the infusion was discontinued and saline 5 ml, edrophonium 0.75 mg kg-1, pyridostigmine 0.24 mg kg-1 or neostigmine 0.05 mg kg-1 was given. Fifteen minutes later the mean durations of a second bolus of suxamethonium were: 10.5 (SD 3.9) min (saline), 10.9 (3.7) min (edrophonium), 18.7 (5.4) min (pyridostigmine) and 23.8 (7.4) min (neostigmine). Corresponding plasma cholinesterase activities (percentage of baseline) were: 91 (18), 87 (9), 21 (10) and 52 (26). When both treatment groups and individual patients were compared, the changes in duration of action did not correlate with changes in cholinesterase activity. These data suggest that other mechanisms in addition to cholinesterase inhibition may contribute to this drug interaction.


Subject(s)
Cholinesterase Inhibitors/pharmacology , Neuromuscular Depolarizing Agents/pharmacology , Neuromuscular Junction/drug effects , Succinylcholine/pharmacology , Adult , Aged , Anesthesia, General , Cholinesterases/blood , Drug Interactions , Edrophonium/pharmacology , Female , Humans , Male , Middle Aged , Neostigmine/pharmacology , Neuromuscular Nondepolarizing Agents/antagonists & inhibitors , Pyridostigmine Bromide/pharmacology , Vecuronium Bromide/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL